Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neutropenia × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 40 Breast 37 Classical hematology 34 Lymphoid 22 Myeloid 9 Thoracic 7 Gynecologic 7 Gastrointestinal 7 Dermatologic 7 Sarcoma 6 Plasma cell 6 Genitourinary 4 CNS 4 Other solid neoplasm 1 Other neoplasm 1 Other 1

Conditions

Obesity 248 Mucositis 94 Neoplasms 92 Breast Neoplasms 76 Overweight 66 Sexual Dysfunction, Physiological 61 Polycystic Ovary Syndrome 60 Dyspnea 43 Constipation 37 Motor Activity 35 Head and Neck Neoplasms 34 Weight Loss 29 Prostatic Neoplasms 27 Pain 24 Stomatitis 22 Opioid-Induced Constipation 20 Multiple Endocrine Neoplasia Type 1 16 Lung Neoplasms 16 Endometrial Neoplasms 16 Colorectal Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Sexual Dysfunctions, Psychological 13 Diabetes Mellitus 13 Sedentary Behavior 12 Depression 12 Colonic Neoplasms 12 Cancer-related Fatigue 12 Anxiety Disorders 12 Leukemia 11 Insulin Resistance 11

Interventions

fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡